Mouse Anti-FHL2 Recombinant Antibody (CBXF-1496) (V2LY-0925-LY1939)

Algaber, A., Madhi, R., Hawez, A., Rönnow, C. F., & Rahman, M. (2021). Targeting FHL2‑E‑cadherin axis by miR‑340‑5p attenuates colon cancer cell migration and invasion. Oncology Letters, 22(2), 1-11.

Clemente-Olivo, M. P., Habibe, J. J., Vos, M., Ottenhoff, R., Jongejan, A., Herrema, H., ... & de Vries, C. J. (2021). Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity. Metabolism, 121, 154815.

Habibe, J. J., Clemente-Olivo, M. P., & de Vries, C. J. (2021). How (Epi) Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease. Cells, 10(10), 2611.

Sommer, J., & Hellerbrand, C. (2020). Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatocellular Carcinoma. Zeitschrift für Gastroenterologie, 58(01), 4-18.

Wang, C., Lv, X., He, C., Davis, J. S., Wang, C., & Hua, G. (2020). Four and a half lim domains 2 (FHL2) contribute to the epithelial ovarian cancer carcinogenesis. International journal of molecular sciences, 21(20), 7751.

Sommer, J., Dorn, C., Gäbele, E., Bataille, F., Freese, K., Seitz, T., ... & Hellerbrand, C. (2020). Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury. Cells, 9(1), 248.

Zhang, L., Li, R., Chen, L., Xing, Z., Song, Y., Nie, X., ... & Tian, S. (2020). Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine. Reproduction in Domestic Animals, 55(6), 737-746.

Sommer, J., Dorn, C., Weiskirchen, R., & Hellerbrand, C. (2020). Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis. Zeitschrift für Gastroenterologie, 58(01), 1-7.

Nishikawa, M., Sato, K., Nakano, S., Yamakawa, H., Nagase, T., & Ueda, H. (2019). Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3. Small GTPases, 10(5), 361-366.

Liang, Y., Bradford, W. H., Zhang, J., & Sheikh, F. (2018). Four and a half LIM domain protein signaling and cardiomyopathy. Biophysical reviews, 10(4), 1073-1085.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols